Navana Pharmaceuticals PLC
64.50
BDT
-0.90
-1.38%
Last updated on 21 Sep, 14:11
Today
-1.38%
1 Week
6.97%
1 Month
-5.15%
6 Month
10.82%
1 Year
14.36%
5 Year
-
Matket Today
Open
65.5
BDT
Low
64.4
BDT
High
66.4
BDT
Volume
357781
Value
2.34
Crore
Trade
939
YCP
65.4
BDT
52W Low
45.5
BDT
52W High
78
BDT
Circuit Low
58.9
BDT
Circuit Up
71.9
BDT
Beta (1 Year)
1.45
Financial Indicators
P/E ratio
10.61
EPS (TTM)
6.08
NAV (Q3 2026)
49.53
Total Shares
10.74
Crore
Shot-term loan
5.18
Crore
Long-term loan
1.10
Crore
Market Capital
702.50
Crore
Paid-up Capital
107.42
Crore
Authorized Capital
200
Crore
Last AGM Date
31 Dec 2025
Last Record Date
19 Nov 2025
Year End
30-Jun
About Navana Pharmaceuticals PLC
Sector
Pharmaceuticals & Chemicals
Listing Year
2022
cs@navanapharma.com
Navana Pharmaceuticals Ltd. (NPL) has been expanding its business since 1992, emphasizing innovation and quality products. The company operates in Veterinary and Human Health divisions, manufacturing high-quality veterinary medicine and pharmaceutical products under strict compliance with WHO cGMP guidelines. NPL prioritizes people quality, process development, and utilizes ICT. Adhering to WHO cGMP and QMS principles, the company focuses on built-in quality at every stage. NPL is growing in both domestic and international markets, showcasing its commitment to excellence in the pharmaceutical industry.